Management of uncommon chemotherapy-induced emergencies
LANCET ONCOLOGY (2011)
Journal
LANCET ONCOLOGY
Volume 12, Issue 8, Pages 806-814Publisher
ELSEVIER SCIENCE INC
Keywords
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
Chemotherapy-induced gastrointestinal toxicity: Pathogenesis and current management
Yunjing He, Jingrui Zheng, Binbin Ye, Yongzhao Dai, Ke Nie
BIOCHEMICAL PHARMACOLOGY (2023)
Knowing the unknowns: Uncertainties during radiological emergencies
Ferdiana Hoti, Tanja Perko, Vasiliki Tafili, Roser Sala, Nadja Zeleznik, Yevgeniya Tomkiv, Catrinel Turcanu, Peter Thijssen, Ortwin Renn
INTERNATIONAL JOURNAL OF DISASTER RISK REDUCTION (2021)
Spontaneous volunteer coordination during disasters and emergencies: Opportunities, challenges, and risks
Leila Daddoust, Ali Asgary, Kenneth J. McBey, Steve Elliott, Alain Normand
INTERNATIONAL JOURNAL OF DISASTER RISK REDUCTION (2021)
Neonatal neurologic emergencies requiring access to paediatric emergency units: a retrospective observational study
Raffaele Falsaperla, Giovanna Vitaliti, Monica Sciacca, Lucia Tardino, Simona Domenica Marino, Silvia Marino, Carla Moscheo, Mariaclaudia Meli, Maria Concetta Vitaliti, Massimo Barbagallo, Vita Antonella Di Stefano, Marco Andrea Nicola Saporito, Martino Ruggieri
SCIENTIFIC REPORTS (2022)
An uncommon perineal embryonal rhabdomyosarcoma in adult: A case report
Sifeng Qu, Weiwei Li, Yuan Yao, Huangwei Huang
MEDICINE (2022)
Mechanisms of Chemotherapy-Induced Neurotoxicity
Halina Was, Agata Borkowska, Ana Bagues, Longlong Tu, Julia Y. H. Liu, Zengbing Lu, John A. Rudd, Kulmira Nurgali, Raquel Abalo
FRONTIERS IN PHARMACOLOGY (2022)
Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult Rhabdomyosarcomas
Alessandro De Vita, Silvia Vanni, Valentina Fausti, Claudia Cocchi, Federica Recine, Giacomo Miserocchi, Chiara Liverani, Chiara Spadazzi, Massimo Bassi, Manlio Gessaroli, Angelo Campobassi, Giovanni De Luca, Federica Pieri, Anna Farnedi, Eugenia Franchini, Anna Ferrari, Chiara Domizio, Enrico Cavagna, Lorena Gurrieri, Alberto Bongiovanni, Nada Riva, Sebastiano Calpona, Giandomenico Di Menna, Silvia Angela Debonis, Toni Ibrahim, Laura Mercatali
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Individual Medical Emergencies Occurring at School
Rani S. Gereige, Toni Gross, Ebaa Jastaniah
PEDIATRICS (2022)
A Survey of Emergencies Management Systems in Smart Cities
Daniel G. Costa, Joao Paulo J. Peixoto, Thiago C. Jesus, Paulo Portugal, Francisco Vasques, Elivelton Rangel, Maycon Peixoto
IEEE ACCESS (2022)
Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: An update
Allison D. Desforges, Chance M. Hebert, Allyson L. Spence, Bailey Reid, Hemangini A. Dhaibar, Diana Cruz-Topete, Elyse M. Cornett, Alan David Kaye, Ivan Urits, Omar Viswanath
BIOMEDICINE & PHARMACOTHERAPY (2022)
Integrated Healthcare and the Dilemma of Public Health Emergencies
Krzysztof Goniewicz, Eric Carlstrom, Attila J. Hertelendy, Frederick M. Burkle, Mariusz Goniewicz, Dorota Lasota, John G. Richmond, Amir Khorram-Manesh
SUSTAINABILITY (2021)
Inhibition of GABAA receptors in intestinal stem cells prevents chemoradiotherapy-induced intestinal toxicity
Cuiyu Zhang, Yuping Zhou, Junjie Zheng, Nannan Ning, Haining Liu, Wenyang Jiang, Xin Yu, Kun Mu, Yan Li, Wei Guo, Huili Hu, Jingxin Li, Dawei Chen
JOURNAL OF EXPERIMENTAL MEDICINE (2022)
Nano shield: a new tetrahedral framework nucleic acids-based solution to radiation-induced mucositis
Geru Zhang, Liwei Huang, Maogeng Feng, Tianxu Zhang, Yang Gao, Yangxue Yao, Songhang Li, Xiaobing Li, Yunfeng Lin
NANOSCALE (2023)
Intelligent Vacuum-Assisted Biopsy to Identify Breast Cancer Patients With Pathologic Complete Response (ypT0 and ypN0) After Neoadjuvant Systemic Treatment for Omission of Breast and Axillary Surgery
Andre Pfob, Chris Sidey-Gibbons, Geraldine Rauch, Bettina Thomas, Benedikt Schaefgen, Sherko Kuemmel, Toralf Reimer, Markus Hahn, Marc Thill, Jens-Uwe Blohmer, John Hackmann, Wolfram Malter, Inga Bekes, Kay Friedrichs, Sebastian Wojcinski, Sylvie Joos, Stefan Paepke, Tom Degenhardt, Joachim Rom, Achim Rody, Marion van Mackelenbergh, Maggie Banys-Paluchowski, Regina Grosse, Mattea Reinisch, Maria Karsten, Michael Golatta, Joerg Heil
JOURNAL OF CLINICAL ONCOLOGY (2022)
An ontology-based system for discovering landslide-induced emergencies in electrical grid
Jedsada Phengsuwan, Tejal Shah, Rui Sun, Philip James, Dhavalkumar Thakker, Rajiv Ranjan
TRANSACTIONS ON EMERGING TELECOMMUNICATIONS TECHNOLOGIES (2022)
Radiotherapy in the Management of Paediatric Low-Grade Gliomas
T. Ajithkumar, R. Taylor, R. D. Kortmann
CLINICAL ONCOLOGY (2019)
Indeed, Cure is Not Enough - A Reflection on Paediatric Radiation Oncology
T. Ajithkumar, R. D. Kortmann
CLINICAL ONCOLOGY (2019)
Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE radiotherapy working group
Bianca A. Hoeben, Christian Carrie, Beate Timmermann, Henry C. Mandeville, Lorenza Gandola, Karin Dieckmann, Monica Ramos Albiac, Henriette Magelssen, Yasmin Lassen-Ramshad, Barbora Ondrova, Thankamma Ajithkumar, Claire Alapetite, Brian V. Balgobind, Stephanie Bolle, Alison L. Cameron, Raquel Davila Fajardo, Stefan Dietzsch, Delphine Dumont Lecomte, Marry M. van den Heuvel-Eibrink, Rolf D. Kortmann, Anne Laprie, Patrick Melchior, Laetitia Padovani, Barbara Rombi, Giovanni Scarzello, Rudolf Schwarz, Klaus Seiersen, Enrica Seravalli, Nicola Thorp, Gillian A. Whitfield, Tom Boterberg, Geert O. Janssens
LANCET ONCOLOGY (2019)
Treating Brain Metastases from Breast Cancer: Outcomes after Stereotactic Radiosurgery
T. G. Wilson, T. Robinson, C. MacFarlane, T. Spencer, C. Herbert, L. Wade, H. Reed, J. P. Braybrooke
CLINICAL ONCOLOGY (2020)
Trastuzumab Beyond Progression in Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: UK Practice now and in the Future
T. Robinson, C. Palmieri, J. P. Braybrooke
CLINICAL ONCOLOGY (2020)
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials
Jan Hudecek, Leonie Voorwerk, Maartje van Seijen, Iris Nederlof, Michiel de Maaker, Jose van den Berg, Koen K. van de Vijver, Karolina Sikorska, Sylvia Adams, Sandra Demaria, Giuseppe Viale, Torsten O. Nielsen, Sunil S. Badve, Stefan Michiels, William Fraser Symmans, Christos Sotiriou, David L. Rimm, Stephen M. Hewitt, Carsten Denkert, Sibylle Loibl, Sherene Loi, John M. S. Bartlett, Giancarlo Pruneri, Deborah A. Dillon, Maggie C. U. Cheang, Andrew Tutt, Jacqueline A. Hall, Zuzana Kos, Roberto Salgado, Marleen Kok, Hugo M. Horlings
NPJ BREAST CANCER (2020)
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group
Mohamed Amgad, Elisabeth Specht Stovgaard, Eva Balslev, Jeppe Thagaard, Weijie Chen, Sarah Dudgeon, Ashish Sharma, Jennifer K. Kerner, Carsten Denkert, Yinyin Yuan, Khalid AbdulJabbar, Stephan Wienert, Peter Savas, Leonie Voorwerk, Andrew H. Beck, Anant Madabhushi, Johan Hartman, Manu M. Sebastian, Hugo M. Horlings, Jan Hudecek, Francesco Ciompi, David A. Moore, Rajendra Singh, Elvire Roblin, Marcelo Luiz Balancin, Marie-Christine Mathieu, Jochen K. Lennerz, Pawan Kirtani, I-Chun Chen, Jeremy P. Braybrooke, Giancarlo Pruneri, Sandra Demaria, Sylvia Adams, Stuart J. Schnitt, Sunil R. Lakhani, Federico Rojo, Laura Comerma, Sunil S. Badve, Mehrnoush Khojasteh, W. Fraser Symmans, Christos Sotiriou, Paula Gonzalez-Ericsson, Katherine L. Pogue-Geile, Rim S. Kim, David L. Rimm, Giuseppe Viale, Stephen M. Hewitt, John M. S. Bartlett, Frederique Penault-Llorca, Shom Goel, Huang-Chun Lien, Sibylle Loibl, Zuzana Kos, Sherene Loi, Matthew G. Hanna, Stefan Michiels, Marleen Kok, Torsten O. Nielsen, Alexander J. Lazar, Zsuzsanna Bago-Horvath, Loes F. S. Kooreman, Jeroen A. W. M. van der Laak, Joel Saltz, Brandon D. Gallas, Uday Kurkure, Michael Barnes, Roberto Salgado, Lee A. D. Cooper
NPJ BREAST CANCER (2020)
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
Zuzana Kos, Elvire Roblin, Rim S. Kim, Stefan Michiels, Brandon D. Gallas, Weijie Chen, Koen K. van de Vijver, Shom Goel, Sylvia Adams, Sandra Demaria, Giuseppe Viale, Torsten O. Nielsen, Sunil S. Badve, W. Fraser Symmans, Christos Sotiriou, David L. Rimm, Stephen Hewitt, Carsten Denkert, Sibylle Loibl, Stephen J. Luen, John M. S. Bartlett, Peter Savas, Giancarlo Pruneri, Deborah A. Dillon, Maggie Chon U. Cheang, Andrew Tutt, Jacqueline A. Hall, Marleen Kok, Hugo M. Horlings, Anant Madabhushi, Jeroen van der Laak, Francesco Ciompi, Anne-Vibeke Laenkholm, Enrique Bellolio, Tina Gruosso, Stephen B. Fox, Juan Carlos Araya, Giuseppe Floris, Jan Hudecek, Leonie Voorwerk, Andrew H. Beck, Jen Kerner, Denis Larsimont, Sabine Declercq, Gert Van den Eynden, Lajos Pusztai, Anna Ehinger, Wentao Yang, Khalid AbdulJabbar, Yinyin Yuan, Rajendra Singh, Crispin Hiley, Maise al Bakir, Alexander J. Lazar, Stephen Naber, Stephan Wienert, Miluska Castillo, Giuseppe Curigliano, Maria-Vittoria Dieci, Fabrice Andre, Charles Swanton, Jorge Reis-Filho, Joseph Sparano, Eva Balslev, I-Chun Chen, Elisabeth Ida Specht Stovgaard, Katherine Pogue-Geile, Kim R. M. Blenman, Frederique Penault-Llorca, Stuart Schnitt, Sunil R. Lakhani, Anne Vincent-Salomon, Federico Rojo, Jeremy P. Braybrooke, Matthew G. Hanna, M. Teresa Soler-Monso, Daniel Bethmann, Carlos A. Castaneda, Karen Willard-Gallo, Ashish Sharma, Huang-Chun Lien, Susan Fineberg, Jeppe Thagaard, Laura Comerma, Paula Gonzalez-Ericsson, Edi Brogi, Sherene Loi, Joel Saltz, Frederick Klaushen, Lee Cooper, Mohamed Amgad, David A. Moore, Roberto Salgado
NPJ BREAST CANCER (2020)
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer
Andrew N. J. Tutt, Judy E. Garber, Bella Kaufman, Giuseppe Viale, Debora Fumagalli, Priya Rastogi, Richard D. Gelber, Evandro de Azambuja, Anitra Fielding, Judith Balmana, Susan M. Domchek, Karen A. Gelmon, Simon J. Hollingsworth, Larissa A. Korde, Barbro Linderholm, Hanna Bandos, E. Senkus, Jennifer M. Suga, Z. Shao, Andrew W. Pippas, Zbigniew Nowecki, Tomasz Huzarski, Patricia A. Ganz, Peter C. Lucas, Nigel Baker, Sibylle Loibl, Robin McConnell, Martine Piccart, Rita Schmutzler, Guenther G. Steger, Joseph P. Costantino, Amal Arahmani, Norman Wolmark, Eleanor McFadden, Vassiliki Karantza, Sunil R. Lakhani, Greg Yothers, Christine Campbell, Charles E. Geyer
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials
R. Bradley, J. Braybrooke, R. Gray, R. K. Hills, Z. Liu, H. Pan, R. Peto, D. Dodwell, P. McGale, C. Taylor, J. Bergh, S. Swain, P. A. Francis, M. Gnant, F. Perrone, M. M. Regan
LANCET ONCOLOGY (2022)
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
Khalid El Bairi, Harry R. Haynes, Elizabeth Blackley, Susan Fineberg, Jeffrey Shear, Sophia Turner, Juliana Ribeiro de Freitas, Daniel Sur, Luis Claudio Amendola, Masoumeh Gharib, Amine Kallala, Indu Arun, Farid Azmoudeh-Ardalan, Luciana Fujimoto, Luz F. Sua, Shi-Wei Liu, Huang-Chun Lien, Pawan Kirtani, Marcelo Balancin, Hicham El Attar, Prerna Guleria, Wenxian Yang, Emad Shash, I-Chun Chen, Veronica Bautista, Jose Fernando Do Prado Moura, Bernardo L. Rapoport, Carlos Castaneda, Eunice Spengler, Gabriela Acosta-Haab, Isabel Frahm, Joselyn Sanchez, Miluska Castillo, Najat Bouchmaa, Reena R. Md Zin, Ruohong Shui, Timothy Onyuma, Wentao Yang, Zaheed Husain, Karen Willard-Gallo, An Coosemans, Edith A. Perez, Elena Provenzano, Paula Gonzalez Ericsson, Eduardo Richardet, Ravi Mehrotra, Sandra Sarancone, Anna Ehinger, David L. Rimm, John M. S. Bartlett, Giuseppe Viale, Carsten Denkert, Akira I. Hida, Christos Sotiriou, Sibylle Loibl, Stephen M. Hewitt, Sunil Badve, William Fraser Symmans, Rim S. Kim, Giancarlo Pruneri, Shom Goel, Prudence A. Francis, Gloria Inurrigarro, Rin Yamaguchi, Hernan Garcia-Rivello, Hugo Horlings, Said Afqir, Roberto Salgado, Sylvia Adams, Marleen Kok, Maria Vittoria Dieci, Stefan Michiels, Sandra Demaria, Sherene Loi
NPJ BREAST CANCER (2021)
Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy
P. J. Ross, H. S. Wasan, D. Croagh, M. Nikfarjam, N. Nguyen, M. Aghmesheh, A. M. Nagrial, D. Bartholomeusz, A. Hendlisz, T. Ajithkumar, C. Iwuji, N. E. Wilson, D. M. Turner, D. C. James, E. Young, M. T. Harris
ESMO OPEN (2022)
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)
Johnathan K. Joffe, Fay H. Cafferty, Laura Murphy, Gordon J. S. Rustin, Syed A. Sohaib, Rhian Gabe, Sally P. Stenning, Elizabeth James, Dipa Noor, Simona Wade, Francesca Schiavone, Sarah Swift, Elaine Dunwoodie, Marcia Hall, Anand Sharma, Jeremy Braybrooke, Jonathan Shamash, John Logue, Henry H. Taylor, Ivo Hennig, Jeff White, Sarah Rudman, Jane Worlding, David Bloomfield, Guy Faust, Hilary Glen, Rachel Jones, Michael Seckl, Graham MacDonald, Thiagarajan Sreenivasan, Satish Kumar, Andrew Protheroe, Ramachandran Venkitaraman, Danish Mazhar, Victoria Coyle, Martin Highley, Tom Geldart, Robert Laing, Richard S. Kaplan, Robert A. Huddart
JOURNAL OF CLINICAL ONCOLOGY (2022)
Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials
J. Bergh, K. Pritchard, S. Swain, D. Cameron, K. Albain, S. Anderson, R. Arriagada, J. Bartlett, E. Bergsten-Nordstrom, J. Bliss, R. Bradley, E. Brain, J. Braybrooke, L. Carey, M. Clarke, R. Coleman, J. Cuzick, N. Davidson, L. Del Mastro, A. Di Leo, J. Dignam, D. Dodwell, M. Dowsett, F. Duane, B. Ejlertsen, P. Francis, R. Gelber, M. Gnant, M. Goetz, P. Goodwin, R. Gray, P. Halpin-Murphy, D. Hayes, C. Hill, R. Jagsi, W. Janni, Z. Liu, S. Loibl, E. MacKinnon, E. Mamounas, G. Mannu, M. Martin, P. McGale, H. Mukai, V Nekljudova, L. Norton, Y. Ohashi, H. Pan, R. Peto, M. Piccart, L. Pierce, P. Poortmans, V Raina, D. Rea, M. Regan, J. Robertson, E. Rutgers, D. Slamon, T. Spanic, J. Sparano, G. Steger, C. Taylor, G. Tang, M. Toi, A. Tutt, G. Viale, X. Wang, T. Whelan, N. Wilcken, N. Wolmark
LANCET ONCOLOGY (2021)
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial
Nicholas C. Turner, Belinda Kingston, Lucy S. Kilburn, Sarah Kernaghan, Andrew M. Wardley, Iain R. Macpherson, Richard D. Baird, Rebecca Roylance, Peter Stephens, Olga Oikonomidou, Jeremy P. Braybrooke, Mark Tuthill, Jacinto Abraham, Matthew C. Winter, Hannah Bye, Michael Hubank, Heidrun Gevensleben, Ros Cutts, Claire Snowdon, Daniel Rea, David Cameron, Abeer Shaaban, Katrina Randle, Sue Martin, Katie Wilkinson, Laura Moretti, Judith M. Bliss, Alistair Ring
LANCET ONCOLOGY (2020)